Cardinex 4000 Anti-Xa IU/0.4 ml (SC Injection)
0.4 ml pre-filled syringe: ৳ 400.00
Medicine Details
Category | Details |
---|---|
Generic | Enoxaparin sodium |
Company | Drug international ltd |
Also available as |
Title
- Cardinex
Categories
- Medicine
- Anticoagulant
Description
- Enoxaparin Sodium BP
- Low molecular weight heparin
- Anti-Xa activity
- Pre-filled syringe
- Subcutaneous injection
- Pharmacological action
- Dosage instructions
- Injection site preparation
- Interaction with other medications
- Contraindications
- Side effects
- Pregnancy and lactation
- Storage conditions
Dosage
- 0.2 ml pre-filled syringe contains 20 mg Enoxaparin Sodium
- 0.4 ml pre-filled syringe contains 40 mg Enoxaparin Sodium
- 0.6 ml pre-filled syringe contains 60 mg Enoxaparin Sodium
- 0.8 ml pre-filled syringe contains 80 mg Enoxaparin Sodium
Indications
- Deep vein thrombosis treatment
- Unstable angina and non-Q-wave myocardial infarction treatment
- Prevention of thrombus formation during hemodialysis
- Prophylaxis of venous thromboembolic disease
Pharmacology
- High anti-Xa activity
- Low anti-lla activity
- No impact on bleeding time
- Metabolized in the liver
Composition
- Enoxaparin Sodium BP 20 mg equivalent to 2000 anti-Xa III
- Enoxaparin Sodium BP 40 mg equivalent to 4000 anti-Xa III
- Enoxaparin Sodium BP 60 mg equivalent to 6000 anti-Xa UI
- Enoxaparin Sodium BP 80 mg equivalent to 8000 anti-Xa UI
Administration
- Subcutaneous injection
- Injection site preparation and selection
- Dose selection and adjustment based on body weight
- Disposal of used syringes
Interaction
- Discontinue agents affecting hemostasis prior to therapy
- Careful clinical and laboratory monitoring
Contraindications
- Hypersensitivity to Enoxaparin Sodium or heparin
- Active major bleeding
- High risk of uncontrolled hemorrhage
Side Effects
- Haemorrhage
- Thrombocytopenia
- Elevations of serum aminotransferase
- Pain at injection sites
- Skin rash at injection sites
- Neuraxial hematomas with spinal anesthesia
Pregnancy & Lactation
- Pregnancy category B
- No evidence of crossing placental barrier
- Use during pregnancy only if clearly needed
- Unknown excretion in human milk
Precautions & Warnings
- Deep subcutaneous injection
- Do not administer by intramuscular route
- Use with caution in conditions with increased potential for bleeding
- Platelet count monitoring before and during treatment
Use in Special Populations
- No dosage adjustment in elderly patients
- Observation in renal impairment patients
- Caution in hepatically impaired patients
Overdose Effects
- Hemorrhagic complications
- Neutralization with protamine sulfate
Therapeutic Class
- Parenteral anticoagulants
Storage Conditions
- Cool and dry storage
- Protection from light and moisture
- Storage below 25°C
- Keep out of reach of children
Related Brands
- Xaparin 6000 Anti-Xa IU/0.6 ml (SC Injection) - acme-laboratories-ltd
- Xaparin 4000 Anti-Xa IU/0.4 ml (SC Injection) - acme-laboratories-ltd
- Enorin 8000 Anti-Xa IU/0.8 ml (SC Injection) - eskayef-pharmaceuticals-ltd
- Enorin 6000 Anti-Xa IU/0.6 ml (SC Injection) - eskayef-pharmaceuticals-ltd
- Enorin 4000 Anti-Xa IU/0.4 ml (SC Injection) - eskayef-pharmaceuticals-ltd